Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...

Lilly expects full-year earnings in the range of $22.50 to $24 per share, with revenue in the range of $58 billion to $61 billion. This story was generated by Automated Insights ( ...

Stocks on Wall Street edged higher Wednesday as the focus swings back toward how much profit businesses are making.

Negotiations between Nissan and Honda are reportedly shaky after the two Japanese automakers previously announced they would ...

Federal workers say they're in a mode of fear, shock and uncertainty as they decide whether to accept President Trump's ...